{{Rsnum
|rsid=998075
|Gene=IGF2R
|Chromosome=6
|position=160047246
|Orientation=minus
|GMAF=0.4302
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=IGF2R
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 19.5 | 51.3 | 29.2
| HCB | 48.2 | 38.7 | 13.1
| JPT | 47.8 | 44.2 | 8.0
| YRI | 39.5 | 49.7 | 10.9
| ASW | 36.8 | 40.4 | 22.8
| CHB | 48.2 | 38.7 | 13.1
| CHD | 45.0 | 44.0 | 11.0
| GIH | 32.7 | 50.5 | 16.8
| LWK | 24.5 | 60.9 | 14.5
| MEX | 36.2 | 37.9 | 25.9
| MKK | 26.3 | 53.8 | 19.9
| TSI | 23.5 | 47.1 | 29.4
| HapMapRevision=28
}}{{PMID|17684144}} related IGF2R Ex16+88G>A [[rs998075]] alters [[methylation]] affecting [[osteosarcoma]]

{{PMID Auto
|PMID=20302654
|Title=Genotypes and haplotypes in the insulin-like growth factors, their receptors and binding proteins in relation to plasma metabolic levels and mammographic density.
|OA=1
}}

{{PMID Auto
|PMID=20403199
|Title=High-throughput analysis of candidate imprinted genes and allele-specific gene expression in the human term placenta.
|OA=1
}}

{{PMID Auto
|PMID=21437228
|Title=Using epidemiology and genomics to understand osteosarcoma etiology.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}